Skip to content
AwardedPOLGoods

Dostawa produktu leczniczego zawierającego substancję czynną Farycymab,

Published
Published 11 May 2026

Overview

Uniwersytecki Szpital Kliniczny Nr 1 w Lublinie has procured a pharmaceutical product containing the active substance Farycymab. The contract, valued at 939,314.88 PLN, was awarded to Roche Polska Sp. z o.o. on 27 April 2026.

Key details

Country
POL
Status
Awarded
Category
Goods
Published
11 May 2026
Classification (CPV)
Pharmaceutical products

Award outcome

Awarded value
PLN 939,315
Award date
27 April 2026
Contract period
— → 22 April 2027
Winner
  • Roche Polska Sp. z o.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 May 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dostawa produktu leczniczego zawierającego substancję czynną Farycymab, — won by Roche Polska Sp. z o.o. — Skim